Stay updated on Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial

Sign up to get notified when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer now identifies the site as revision v3.8.0 instead of v3.7.2. The study record still displays a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-04T00:29:20.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    An NIH notice about the terminology transition was added, and the site revision changed from v3.7.1 to v3.7.2. The page remains a 403 error page.
    Difference
    1%
    Check dated 2026-10-21T00:31:26.000Z thumbnail image
  4. Check
    30 days ago
    Change Detected
    Summary
    The clinical trial record is no longer displayed; the page now shows a 403 Forbidden error instead of the study details and results.
    Difference
    21%
    Check dated 2026-10-07T00:38:23.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error, so the study details are not displayed. The page shows the error screen instead of the expected content.
    Difference
    21%
    Check dated 2026-09-23T00:43:46.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.6.6 to v3.7.0, indicating a new release of the site's software. This change does not modify the study content displayed on the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:01:52.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Revision: v3.6.6 updated from v3.6.5 on the page, indicating a small maintenance update to the study details page.
    Difference
    0.0%
    Check dated 2026-09-01T20:43:39.000Z thumbnail image

Stay in the know with updates to Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Gemini 1: Dolutegravir/Lamivudine vs Tenofovir/Emtricitabine Clinical Trial page.